NA Proactive news snapshot: Nemaura Medical, XPhyto Therapeutics, HighGold Mining,, Bragg Gaming …

Nemaura Medical Inc (NASDAQ:NMRD), a UK-based medical company focused on diabetes, announced Wednesday it is preparing for the launch of its sugarBEAT continuous glucose monitor in the US under the wellness category following recent feedback from the Food and Drug Administration (FDA). In a statement, the company said it is prioritizing launch plans in the US and is considering various options to expedite the launch, including the potential partnering with multi-national companies. XPhyto Therapeutics Corp (CSE:XPHY), the science-focused cannabis group, has said it will be advancing its cannabidiol (CBD) based Epilepsy program to clinical studies immediately after making significant progress. The firm is now finalizing the formulation and preparing for clinical studies in Europe in the second and third quarter of 2020, it said in a statement. HighGold Mining Inc (CVE:HIGH) (OTCMKTS:HGGOF), the North America-focused explorer, told investors it has temporarily suspended drilling at its Timmins area gold properties in Ontario in the light of the coronavirus outbreak. The resource firm aims to restart operations and complete the remainder of the planned meters later this year when it is appropriate, it said in a statement. Bragg Gaming Group Inc (CVE:BRAG) (OTCMKTS:BRGGF) subsidiary ORYX Gaming said Wednesday that Malta’s CasinoSecret will integrate ORUX Hub into its online platform. The deal gives CasinoSecret access to over 8,000 games from more than 80 third-party suppliers through ORYX Hub. CasinoSecret’s cashback model is unique in the iGaming industry, ORYX said in a statement. It also offers live tournaments with different winning mechanisms. NexTech AR Solutions Corp (CSE:NTAR) (OTCMKTS:NEXCF) told investors Wednesday that the company is seeing a surge in demand for its e-commerce products and augmented reality (AR) technology rise due to COVID-19 forcing a paradigm shift toward working from home. Though it is known primarily for AR, the company actually operates a pair of e-commerce companies that it acquired last year to help hone its technology. In the thick of social distancing, that could pay off to the tune of a record-setting month. TIMIA Capital Corporation (CVE:TCA) (OTCMKTS:TIMCF) announced Wednesday that it has entered into a US$2 million investment facility with Measured Inc. TIMIA said Measure is a leader in media incrementality measurement based in Santa Monica, California.  In a statement, the firm said the financing facility includes an initial disbursement of US$750,000, which has been advanced, and a further US$1.25 million to be disbursed upon certain milestones being met over the term of the agreement. Parallax Health Sciences Inc (OTCMKTS:PRLX) reiterated Wednesday that it plans to manufacture its VT-1000 qualitative and quantitative immunoassay analyzer as a “cost-effective and dependable solution” for a wide range of medical uses, including coronavirus.   “We are committed to our diagnostics testing equipment in the areas of infectious disease, cardiac-related and substances of abuse,” Parallax Health Sciences CEO Paul Arena said in a statement. “We are further committed to delivering a cost-effective and dependable solution for testing coronavirus to the healthcare community during a time when such testing is in high-demand worldwide,” he added. Brain Scientific Inc (OTCMKTS:BRSF) has built a single-use, disposable electroencephalogram (EEG) device, the NeuroCap, which is a sanitary medical device designed to help prevent the spread of the coronavirus (COVID-19).  Aside from general sanitation benefits, some early data implies that the virus has a neurological component in severe cases — raising the stakes for neurologists to avoid spreading the virus through cross-contamination. Brain Scientific pointed to a recent report from three coronavirus-designated hospitals In Wuhan, China, that showed more than one-third of coronavirus patients had some sort of neurological symptom, such as altered consciousness, evidence of skeletal muscle damage and acute cerebrovascular disease. Heritage Cannabis Holdings Corp (CSE:CANN) (OTCMKTS:HERTF) has revealed it is adjusting capacity at its production facilities amid the coronavirus pandemic. Beginning on March 18 this year, the group said it will be focusing on "necessary production to complete current customer shipments" and will temporarily adjust to one shift per location per day until further notice. Aurania Resources Ltd (CVE:ARU) (OTCMKTS:AUIAF) is withdrawing staff from the Cordillera de Cutucu in Ecuador where its flagship project sits after the government has put the country on lockdown amid the coronavirus (COVID-19) epidemic. The firm's Lost Cities - Cutucu project lies in the Jurassic metallogenic belt in the eastern foothills of the Andes. Auryn Resources Inc (TSE:AUG) (NYSEAMERICAN:AUG) on Wednesday provided an update on how coronavirus (COVID-19) is impacting its exploration efforts in Peru and Canada. In a statement, the junior exploration company said it has offered all employees at its corporate offices in Vancouver and Edmonton the option to work from home, aligning it with the federal government’s call that all Canadians work from home where possible. Biocept, Inc. (NASDAQ:BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, said it will release financial results for the three and 12 months ended December 31, 2019 after the market closes on Wednesday, March 25, 2020. The company added that it will host a conference call for the investment community to discuss the results and answer questions at 4.30pm Eastern time (1.30pm Pacific time). Individuals interested in participating on the conference call may do so by dialling (855) 656-0927 for domestic callers, (855) 669-9657 for Canadian callers, or (412) 902-4109 for other international callers. Ximen Mining Corp (CVE:XIM) said the TSX Venture Exchange has accepted for expedited filing documentation relating to a letter agreement, dated March 2, 2020, between it and Saville Resources Inc., under which the company can acquire a 100% interest in six mineral claims covering 380.6 hectares near Greenwood, B.C., known as the Bud claims. In consideration, the company will issue 388,888 shares. Great Bear Resources Ltd. (CVE:GBR) has been reiterated as a ‘buy’ by Jay Taylor in the February 17, 2020 edition of Gold, Energy & Tech Stocks. Taylor has said buy four times from February 15, 2018, to October 15, 2019, at prices ranging from $0.53 cents to $6.62 a share. Great Bear owns the Dixie gold project in Ontario, and Taylor says that although Dixie's drill results have long captivated him, it is clear, based on the company’s modest market cap of $300 million, that the market still does not understand "just how big and profitable the Dixie property can become." He runs some back-of-the-envelope calculations and surmises that Dixie could easily contain 10 million to 20 million ounces of gold. Ultimately, he continues to believe that Dixie will one day attract the attention of a major miner, allowing shareholders of Great Bear to "enjoy value from Dixie for years to come."